NOVENTURE will be present at the FNM 2018 Annual Meeting to be held in Amsterdam, 29 August – 1 September
https://doi.org/10.1016/S0016-5085(18)33080-4
BACKGROUND: Irritable Bowel Syndrome (IBS) is a common disorder characterized by…
Gelsectan®, Noventure´s new medical device intended for IBS-D, was presented at Noventure´s stand during the 3rd Meeting of the Federation of Neurogastroenterology and Motility, from 29 August to…
Allergy Asthma Clin Immunol. 2017 Aug 10;13:37 Full text free!!
Abstract:
…Current Medical Research and Opinion 2017. June 10: 1-17
Background:
This study assessed the efficacy,…
NOVENTURE will be present at Gastro Update Europe 2019, in Budapest, June 14 – 15, 2019. Visit us at our stand to learn about Gelsectan, our…
